01
GHK-Cu
GHK binds copper and affects signalling associated with skin matrix and repair.
GHK-Cu 50 + BPC-157 10 + TB-500 10 + KPV 10 mg
KLOW
GHK-Cu · Repair · Actin
KLOW adds KPV to the GLOW formulation. The fixed ratio has not been studied in human trials, and routes and concentrations in component studies do not match this commercial blend.
4Overview
1× / dayReference frequency
DataIndirect component evidence
Research status
Not clinically studied as a combination
KLOW80 MG
01 · Overview
What is KLOW?
KLOW adds KPV to the GLOW formulation. The fixed ratio has not been studied in human trials, and routes and concentrations in component studies do not match this commercial blend.
Research route, formulation and population determine what a result actually means.
02
Repair
Studies cell migration, vessel formation and matrix repair in wound models.
03
Actin
Thymosin-β4 binds actin and influences cell migration and wound repair.
02 · Research
What do the studies show?
Indirect component evidence. Educational information. Not diagnosis, treatment or use advice.
4
No direct studyFour components
More components create more potential interactions; no combination pharmacokinetic or safety data exist.
Mice
PreclinicalKPV research
KPV reduced inflammatory signalling in cells and mouse colitis models; this is not evidence for the KLOW blend.
03 · DATA
Peptide and product specifications
Checked identity data for this research compound or blend.
KLOWPeptide and product specifications
Product type
Blend; not a single molecule
Components
GHK-Cu + BPC-157 + TB-500 + KPV
Nominal composition
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg (totaal 80 mg)
Combined molecular formula
Not applicable to a blend
Combined CAS number
None; see the individual component pages
Purity
Batch-specific - confirm identity and purity with the Velora COA
Reference diluent
Formulation- and batch-specific; there is no universal diluent for every research compound
Unreconstituted-material storage
Follow the accompanying COA, product label and validated stability data
These are compound references, not a batch certificate. Purity and identity of a specific Velora batch must be confirmed by its accompanying COA and laboratory report.
04 · Calculator
Reconstitution and U-100 conversion
This module only converts concentration and volume. Inputs are not recommendations or individual dosing advice.
Calculator
Once daily in educational blend protocols
1
2
3
4
Draw to
0 units
0.00 mL
KLOW
80 MG
Concentration-
Per unit-
Complete amounts-
Calculated duration-
LAB · RECONSTITUTION
How to reconstitute KLOW for laboratory research
A visual workflow for controlled laboratory reconstitution. Always follow the product label, COA and a validated protocol.
Clean
Disinfect the rubber closures of both vials and allow them to dry.
Measure diluent
Withdraw only the diluent validated for the specific compound.
Add slowly
Let the liquid run slowly down the inside wall of the vial.
Swirl gently
Do not shake; rotate gently until the material has dissolved.
Store per protocol
Follow the product label, COA and validated stability data.
Important checks before and after reconstitution
Check the product
First confirm that the product is a lyophilised vial. Prefilled pens and ready-to-use solutions do not require reconstitution. Check the label, COA and specified diluent.
Use clean, sterile technique
Wash your hands, clean the work surface and use new sterile equipment for every procedure. Clean both rubber closures with separate alcohol swabs and let them dry completely.
Concentration, not total amount
The volume of liquid added changes the concentration in mg per mL, but not the total amount of research compound in the vial. Use the calculator to check this in advance.
Inspect and label
Check for unexpected discoloration, cloudiness or visible particles. Record the compound, concentration and reconstitution date. Storage time and temperature are product-specific; a fixed 28-day rule does not apply to every compound.
General reconstitution volumes listed by the source
General examples, not a product-specific protocol. The chosen volume determines concentration; always check the label, COA and calculator.
| Vial strength | Commonly listed volume |
|---|---|
| 2 mg | 1–2 mL |
| 5 mg | 2–3 mL |
| 6 mg | 2–3 mL |
| 10 mg | 2–4 mL |
| 15 mg | 3–5 mL |
| 20 mg | 4–8 mL |
Practical background source: Free Medical Journals - Complete Step-by-Step Guide to Peptide Reconstitution, accessed July 2026. This is a secondary educational source; the product label, COA and validated stability data remain authoritative.
05 · Safety and limitations
Safety and limitations
Research route, formulation and population determine what a result actually means.
What is known
- Visible research claims use primary or official sources.
- The calculator is arithmetic and does not turn a study amount into medical advice.
- A registered medicine and a research vial are not automatically equivalent.
What remains uncertain
- Many products lack long-term safety data and independent replication.
- Animal and cell findings do not predict a safe human dose.
- Stability depends on formulation, pH, sterility, light, temperature and packaging.
Status: Not clinically studied as a combination. Educational information. Not diagnosis, treatment or use advice.
06 · FAQ
Frequently asked questions
KLOW adds KPV to the GLOW formulation. The fixed ratio has not been studied in human trials, and routes and concentrations in component studies do not match this commercial blend.
More components create more potential interactions; no combination pharmacokinetic or safety data exist. KPV reduced inflammatory signalling in cells and mouse colitis models; this is not evidence for the KLOW blend.
No. It performs arithmetic conversions only. Medical decisions belong with a licensed healthcare professional.
The curve follows the agreed storage model and is not a laboratory result.
2–8 °C. Protect from light and repeated freeze-thaw cycles.